Specific Cancers
- Adrenal Cancer
- Anal Cancer
- Bile Duct Cancer
- Bladder Cancer
- Bone Cancer
- Brain and Central Nervous Cancer
- Breast Cancer
- Carcinoma of Unknown Primary
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Ewing Sarcoma
- Eye Cancer
- Gallbladder Cancer
- Head and Neck Cancer
- Hodgkin Disease
- Kaposi's Sarcoma
- Kidney Cancer
- Laryngeal Cancer
- Leukemia - Acute Lymphocytic Leukemia (ALL)
- Leukemia - Acute Myelocytic (AML)
- Leukemia - Chronic Lymphocytic Leukemia (CLL)
- Leukemia - Chronic Myelogenous Leukemia (CML)
- Leukemia - General
- Liver Cancer
- Lung Cancer
- Malignant Mesothelioma
- Multiple Myeloma
- Non-Hodgkin Lymphoma
- Oral Cancer
- Other Cancers
- Ovarian Cancer
- Pancreatic Cancer
- Penile Cancer
- Pituitary Cancer
- Prostate Cancer
- Skin Cancer - Melanoma
- Skin Cancer - Non-Melanoma
- Soft Tissue Sarcoma
- Stomach Cancer
- Testicular Cancer
- Thymus Cancer
- Thyroid Cancer
- Urethral Cancer
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
What Are the Treatment Statistics for People with Non-Hodgkin Lymphoma?
The treatment options for people with lymphoma depend on the kind of lymphoma and its stage, as well as other factors. If the lymphoma is confined to the lymph nodes, it can sometimes be treated with radiation. If the lymphoma has spread, it's usually treated with chemotherapy alone or along with biologic therapy, depending on the type of lymphoma. If the lymphoma persists or recurs after treatment, it may be treated with high- or low-dose chemotherapy with bone marrow transplants.
According to the American Cancer Society, these are survival rates for all non-Hodgkin lymphoma. Survival rates refers to the number of people who live a specified number of years after the lymphoma diagnosis. The relative survival statistics adjust for other causes of death that are not directly related to the lymphoma. Because these rates are based on patients first diagnosed and treated several years ago, the outlook for newly diagnosed patients may be better. It's important to note that survival rates can vary widely, depending on the type and stage (extent) of the lymphoma, so the numbers below may not apply to a particular person's situation:
The overall five-year relative survival rate is 67 percent.
The overall 10-year relative survival rate is 57 percent.


